Kelsey Goodwin Analyst PerformanceAnalyst at GuggenheimKelsey Goodwin is a stock analyst at Guggenheim in the medical sector, covering 16 publicly traded companies. Over the past year, Kelsey Goodwin has issued 29 stock ratings, including strong buy, buy, and hold recommendations. While full access to Kelsey Goodwin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kelsey Goodwin's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings32 Last 1 YearsBuy Recommendations89.66% 26 Buy RatingsCompanies Covered16 Unique Companies Ratings Distribution29RatingsDistribution of strong buy, buy, hold, and sell ratings by Kelsey Goodwin.RatingPercentageCount Strong Buy3.4%1 ratings Buy86.2%25 ratings Hold10.3%3 ratings Sell0.0%0 ratingsOut of 29 total stock ratings issued by Kelsey Goodwin at Guggenheim, the majority (86.2%) have been Buy recommendations, followed by 10.3% Hold and 3.4% Strong Buy.Best & Worst CallsBest Call0000.0%IPSCMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call0000.0%URGNApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ16 companiesKelsey Goodwin, an analyst at Guggenheim, currently covers 16 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical16 companies100.0%Kelsey Goodwin of Guggenheim specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE12 companies75.0%MED - DRUGS4 companies25.0% Kelsey Goodwin's Ratings History at Guggenheim Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRVMDRevolution Medicines5/7/2026Boost Price Target$145.39$172.00Overweight$0.0000.00% ROISMMTSummit Therapeutics5/1/2026Lower Price Target$15.46$16.00Neutral$0.0000.00% ROIRLMDRelmada Therapeutics3/24/2026Initiated Coverage$5.86$12.00Overweight$0.0000.00% ROIERASErasca3/13/2026Boost Price Target$13.97$18.00Overweight$0.0000.00% ROIACLXArcellx2/25/2026Downgrade$113.76$115.00Neutral$0.0000.00% ROITNGXTango Therapeutics1/16/2026Boost Price Target$11.69$14.00Overweight$0.0000.00% ROIJANXJanux Therapeutics1/16/2026Lower Price Target$13.72$30.00Overweight$0.0000.00% ROIERASErasca1/16/2026Boost Price Target$9.56$11.00Overweight$0.0000.00% ROICGONCG Oncology1/16/2026Boost Price Target$53.07$70.00Overweight$0.0000.00% ROIBDTXBlack Diamond Therapeutics1/16/2026Lower Price Target$2.67$8.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. SMMTSummit Therapeutics1/14/2026Set Price Target$17.11$40.00$0.0000.00% ROITARAProtara Therapeutics1/7/2026Initiated Coverage$5.12$24.00Overweight$0.0000.00% ROIORICOric Pharmaceuticals1/7/2026Initiated Coverage$8.14$22.00Overweight$0.0000.00% ROIERASErasca1/7/2026Initiated Coverage$3.63$5.00Overweight$0.0000.00% ROIBDTXBlack Diamond Therapeutics11/18/2025Initiated Coverage$4.01$9.00Overweight$0.0000.00% ROIBDTXBlack Diamond Therapeutics11/17/2025Upgrade$3.97Strong-Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals11/5/2025Boost Price Target$8.24$26.00Overweight$0.0000.00% ROINUVLNuvalent10/27/2025Boost Price Target$93.39$128.00Overweight$0.0000.00% ROISMMTSummit Therapeutics9/16/2025Set Price Target$18.49$13.00$0.0000.00% ROISMMTSummit Therapeutics8/19/2025Set Price Target$25.11$21.00$0.0000.00% ROINUVLNuvalent8/19/2025Initiated Coverage$75.01$112.00Overweight$0.0000.00% ROIRVMDRevolution Medicines8/18/2025Initiated Coverage$36.45$75.00Overweight$0.0000.00% ROIJANXJanux Therapeutics8/18/2025Initiated Coverage$25.53$42.00Overweight$0.0000.00% ROISMMTSummit Therapeutics8/18/2025Initiated Coverage$26.29$21.00Neutral$0.0000.00% ROICGONCG Oncology8/18/2025Initiated Coverage$26.13$55.00Overweight$0.0000.00% ROIURGNUrogen Pharma8/18/2025Initiated Coverage$19.40$36.00Overweight$0.0000.00% ROITNGXTango Therapeutics8/18/2025Initiated Coverage$7.22$11.00Overweight$0.0000.00% ROIBCAXBicara Therapeutics8/18/2025Initiated Coverage$11.47$36.00Overweight$0.0000.00% ROIURGNUrogen Pharma6/13/2025Reiterated Rating$11.80$30.00Buy$0.0000.00% ROIURGNUrogen Pharma4/29/2025Reiterated Rating$11.21Buy$00.0000.00% ROIIPSCCentury Therapeutics3/28/2025Reiterated Rating$0.55Buy$0.0000.00% ROIIPSCCentury Therapeutics3/21/2025Lower Price Target$0.55$5.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerRaymond James FinancialStifel NicolausBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
